Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2644

1.

Association of obesity with postoperative outcomes after proctectomy.

Sweigert PJ, Chen C, Fahmy JN, Eguia E, Ban KA, deLahunta D, Peters S, Baker MS, Singer MA.

Am J Surg. 2020 Mar 25. pii: S0002-9610(20)30185-9. doi: 10.1016/j.amjsurg.2020.03.028. [Epub ahead of print]

PMID:
32248948
2.

Atlanta Residents' Knowledge Regarding Heavy Metal Exposures and Remediation in Urban Agriculture.

Balotin L, Distler S, Williams A, Peters SJW, Hunter CM, Theal C, Frank G, Alvarado T, Hernandez R, Hines A, Saikawa E.

Int J Environ Res Public Health. 2020 Mar 20;17(6). pii: E2069. doi: 10.3390/ijerph17062069.

3.

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.

Trigo J, Subbiah V, Besse B, Moreno V, López R, Sala MA, Peters S, Ponce S, Fernández C, Alfaro V, Gómez J, Kahatt C, Zeaiter A, Zaman K, Boni V, Arrondeau J, Martínez M, Delord JP, Awada A, Kristeleit R, Olmedo ME, Wannesson L, Valdivia J, Rubio MJ, Anton A, Sarantopoulos J, Chawla SP, Mosquera-Martinez J, D'Arcangelo M, Santoro A, Villalobos VM, Sands J, Paz-Ares L.

Lancet Oncol. 2020 Mar 27. pii: S1470-2045(20)30068-1. doi: 10.1016/S1470-2045(20)30068-1. [Epub ahead of print]

PMID:
32224306
4.

Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study.

Pozzessere C, Bouchaab H, Jumeau R, Letovanec I, Daccord C, Bourhis J, Prior JO, Peters S, Lazor R, Beigelman-Aubry C.

ERJ Open Res. 2020 Mar 16;6(1). pii: 00165-2019. doi: 10.1183/23120541.00165-2019. eCollection 2020 Jan.

5.

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: Review of the literature and personalized risk-based prevention strategy.

Haanen J, Ernstoff MS, Wang Y, Menzies AM, Puzanov I, Grivas P, Larkin J, Peters S, Thompson JA, Obeid M.

Ann Oncol. 2020 Mar 17. pii: S0923-7534(20)36364-X. doi: 10.1016/j.annonc.2020.03.285. [Epub ahead of print] Review.

PMID:
32194150
6.

Antisense Oligonucleotide in LNA-Gapmer Design Targeting TGFBR2-A Key Single Gene Target for Safe and Effective Inhibition of TGFβ Signaling.

Kuespert S, Heydn R, Peters S, Wirkert E, Meyer AL, Siebörger M, Johannesen S, Aigner L, Bogdahn U, Bruun TH.

Int J Mol Sci. 2020 Mar 12;21(6). pii: E1952. doi: 10.3390/ijms21061952.

7.

Destructive maxillary radiolucency in a 20-year-old female.

Lee KC, Peters SM, Pradhan JS, Alfi DM, Koslovsky DA, Philipone EM.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Oct 13. pii: S2212-4403(19)31500-7. doi: 10.1016/j.oooo.2019.10.001. [Epub ahead of print] No abstract available.

PMID:
32173397
8.

84-year-old woman with a right cheek mass.

Canterbury CR, Walton DM, Shackelford AJ, Bergen MS, Peters SM.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Apr 12. pii: S2212-4403(19)30441-9. doi: 10.1016/j.oooo.2019.04.002. [Epub ahead of print] No abstract available.

PMID:
32173386
9.

Neuroplasticity of Cortical Planning for Initiating Stepping Poststroke: A Case Series.

Peters S, Ivanova TD, Lakhani B, Boyd LA, Garland SJ.

J Neurol Phys Ther. 2020 Apr;44(2):164-172. doi: 10.1097/NPT.0000000000000311.

PMID:
32168159
10.

Implementation of an ICU Recovery Clinic at a Tertiary Care Academic Center.

Bakhru RN, Davidson JF, Bookstaver RE, Kenes MT, Peters SP, Welborn KG, Creech OR, Morris PE, Files DC.

Crit Care Explor. 2019 Aug 9;1(8):e0034. doi: 10.1097/CCE.0000000000000034. eCollection 2019 Aug.

11.

Neural reward related-reactions to monetary gains for self and charity are associated with donating behavior in adolescence.

Spaans JP, Peters S, Crone EA.

Soc Cogn Affect Neurosci. 2020 Mar 12. pii: nsaa027. doi: 10.1093/scan/nsaa027. [Epub ahead of print]

12.

Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research.

Dalgas U, Hvid LG, Kwakkel G, Motl RW, de Groot V, Feys P, Op't Eijnde B, Coote S, Beckerman H, Pfeifer K, Streber R, Peters S, Riemann-Lorenz K, Rosenkranz SC, Centonze D, Van Asch P, Bansi J, Sandroff BM, Pilutti LA, Ploughman M, Freeman J, Paul L, Dawes H, Romberg A, Kalron A, Stellmann JP, Friese MA, Heesen C.

Mult Scler. 2020 Mar 12:1352458520910360. doi: 10.1177/1352458520910360. [Epub ahead of print]

PMID:
32162578
13.

Bubbles and Dust: Experimental Results of Dissolution Rates of Metal Salts and Glasses From Volcanic Ash Deposits in Terms of Surface Area, Chemistry, and Human Health Impacts.

Wygel CM, Peters SC, McDermott JM, Sahagian DL.

Geohealth. 2019 Nov 13;3(11):338-355. doi: 10.1029/2018GH000181. eCollection 2019 Nov.

14.

Impact of 24/7/365 Attending Radiologist Coverage on the Turnaround Time of Trauma-Related Imaging Studies Being Finalized Within 48 Hours in an Emergency Radiology Department, Offering a Perspective from a Tertiary Care Hospital.

Jalal S, Ante Z, Ouellette H, Peters S, Munk P, Nicolaou S.

Can Assoc Radiol J. 2020 Mar 11:846537120902046. doi: 10.1177/0846537120902046. [Epub ahead of print]

PMID:
32157902
15.

Is e-cigarette use in non-smoking young adults associated with later smoking? A systematic review and meta-analysis.

Khouja JN, Suddell SF, Peters SE, Taylor AE, Munafò MR.

Tob Control. 2020 Mar 10. pii: tobaccocontrol-2019-055433. doi: 10.1136/tobaccocontrol-2019-055433. [Epub ahead of print] Review.

16.

International Inventory of Occupational Exposure Information: OMEGA-NET.

Peters S, Turner MC, Bugge MD, Vienneau D, Vermeulen R.

Ann Work Expo Health. 2020 Mar 10. pii: wxaa021. doi: 10.1093/annweh/wxaa021. [Epub ahead of print] No abstract available.

PMID:
32155242
17.

Facilitating Growth through Frustration: Using Genomics Research in a Course-Based Undergraduate Research Experience.

Lopatto D, Rosenwald AG, DiAngelo JR, Hark AT, Skerritt M, Wawersik M, Allen AK, Alvarez C, Anderson S, Arrigo C, Arsham A, Barnard D, Bazinet C, Bedard JEJ, Bose I, Braverman JM, Burg MG, Burgess RC, Croonquist P, Du C, Dubowsky S, Eisler H, Escobar MA, Foulk M, Furbee E, Giarla T, Glaser RL, Goodman AL, Gosser Y, Haberman A, Hauser C, Hays S, Howell CE, Jemc J, Johnson ML, Jones CJ, Kadlec L, Kagey JD, Keller KL, Kennell J, Key SCS, Kleinschmit AJ, Kleinschmit M, Kokan NP, Kopp OR, Laakso MM, Leatherman J, Long LJ, Manier M, Martinez-Cruzado JC, Matos LF, McClellan AJ, McNeil G, Merkhofer E, Mingo V, Mistry H, Mitchell E, Mortimer NT, Mukhopadhyay D, Myka JL, Nagengast A, Overvoorde P, Paetkau D, Paliulis L, Parrish S, Preuss ML, Price JV, Pullen NA, Reinke C, Revie D, Robic S, Roecklein-Canfield JA, Rubin MR, Sadikot T, Sanford JS, Santisteban M, Saville K, Schroeder S, Shaffer CD, Sharif KA, Sklensky DE, Small C, Smith M, Smith S, Spokony R, Sreenivasan A, Stamm J, Sterne-Marr R, Teeter KC, Thackeray J, Thompson JS, Peters ST, Van Stry M, Velazquez-Ulloa N, Wolfe C, Youngblom J, Yowler B, Zhou L, Brennan J, Buhler J, Leung W, Reed LK, Elgin SCR.

J Microbiol Biol Educ. 2020 Feb 28;21(1). pii: 21.1.6. doi: 10.1128/jmbe.v21i1.2005. eCollection 2020.

18.

Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement.

Budczies J, Kazdal D, Allgäuer M, Christopoulos P, Rempel E, Pfarr N, Weichert W, Fröhling S, Thomas M, Peters S, Endris V, Schirmacher P, Stenzinger A.

Lung Cancer. 2020 Apr;142:114-119. doi: 10.1016/j.lungcan.2020.01.019. Epub 2020 Feb 1.

PMID:
32143116
19.

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC.

Cho BC, Reinmuth N, Lee KH, Ahn MJ, Luft A, Van den Heuvel M, Dols MC, Smolin A, Vicente D, Moiseyenko V, Antonia SJ, Moulec SL, Robinet G, Natale R, Garon EB, Nakagawa K, Liu F, Thiyagarajah P, Peters S, Rizvi NA.

Ann Oncol. 2019 Apr;30 Suppl 2:ii79-ii80. doi: 10.1093/annonc/mdz094.002. No abstract available.

20.

Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the phase III MYSTIC study.

Reinmuth N, Cho BC, Lee KH, Luft A, Ahn MJ, Schneider J, Shepherd FA, Geater SL, Pápai-Székely Z, Van Ngoc T, Garassino MC, Liu F, Clemett D, Thiyagarajah P, Ouwens M, Scheuring U, Peters S, Rizvi N.

Ann Oncol. 2019 Apr;30 Suppl 2:ii77. doi: 10.1093/annonc/mdz094.003. No abstract available.

21.

Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study.

Owonikoko TK, Kim HR, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodriguez-Cid J, Schenker M, Lee JS, Gutierrez V, Percent I, Morgensztern D, Fairchild J, Baudelet C, Park K.

Ann Oncol. 2019 Apr;30 Suppl 2:ii77. doi: 10.1093/annonc/mdz094. No abstract available.

22.

PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy.

Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, McDonald F, Peters S, Klein AB, Licour M, Garassino MC.

Ann Oncol. 2019 Apr;30 Suppl 2:ii37. doi: 10.1093/annonc/mdz067.017. No abstract available.

23.

IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy.

Peters S, Kim AW, Solomon B, Gandara DR, Dziadziuszko R, Brunelli A, Garassino MC, Reck M, Wang L, To I, Sun SW, Gitlitz BJ, Sandler A, Rizvi N.

Ann Oncol. 2019 Apr;30 Suppl 2:ii30. doi: 10.1093/annonc/mdz064.014. No abstract available.

24.

CT image standardization is superior to larger but heterogeneous data for robust radiomic models.

Vuong D, Bogowicz M, Unkelbach J, Foerster R, Denzler S, Xyrafas A, Pless M, Thierstein S, Peters S, Guckenberger M, Tanadini-Lang S.

Ann Oncol. 2019 Apr;30 Suppl 2:ii20. doi: 10.1093/annonc/mdz066.001. No abstract available.

25.

A Co-Culture Method to Study Neurite Outgrowth in Response to Dental Pulp Paracrine Signals.

Barkley C, Serra R, Peters SB.

J Vis Exp. 2020 Feb 14;(156). doi: 10.3791/60809.

PMID:
32116290
26.

Neural responses for evaluating self and mother traits in adolescence depend on mother-adolescent relationships.

Van der Cruijsen R, Buisman R, Green K, Peters S, Crone EA.

Soc Cogn Affect Neurosci. 2019 May 31;14(5):481-492. doi: 10.1093/scan/nsz023.

27.

Effects of a blend of Saccharomyces cerevisiae-based direct-fed microbial and fermentation products on plasma carbonyl-metabolome and fecal bacterial community of beef steers.

Adeyemi JA, Peters SO, De Donato M, Cervantes AP, Ogunade IM.

J Anim Sci Biotechnol. 2020 Feb 17;11:14. doi: 10.1186/s40104-019-0419-5. eCollection 2020.

28.

Generation and evaluation of a Glaesserella (Haemophilus) parasuis capsular mutant.

Eberle KC, Hau SJ, Luan SL, Weinert LA, Stasko JA, Wang J, Peters SE, Langford PR, Rycroft AN, Wren BW, Maskell DJ, Tucker AW, Brockmeier SL; BRaDP1T Consortium.

Infect Immun. 2020 Feb 24. pii: IAI.00879-19. doi: 10.1128/IAI.00879-19. [Epub ahead of print]

PMID:
32094250
29.

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM, Poppe AY, Buck BH, Field TS, Dowlatshahi D, van Adel BA, Swartz RH, Shah RA, Sauvageau E, Zerna C, Ospel JM, Joshi M, Almekhlafi MA, Ryckborst KJ, Lowerison MW, Heard K, Garman D, Haussen D, Cutting SM, Coutts SB, Roy D, Rempel JL, Rohr AC, Iancu D, Sahlas DJ, Yu AYX, Devlin TG, Hanel RA, Puetz V, Silver FL, Campbell BCV, Chapot R, Teitelbaum J, Mandzia JL, Kleinig TJ, Turkel-Parrella D, Heck D, Kelly ME, Bharatha A, Bang OY, Jadhav A, Gupta R, Frei DF, Tarpley JW, McDougall CG, Holmin S, Rha JH, Puri AS, Camden MC, Thomalla G, Choe H, Phillips SJ, Schindler JL, Thornton J, Nagel S, Heo JH, Sohn SI, Psychogios MN, Budzik RF, Starkman S, Martin CO, Burns PA, Murphy S, Lopez GA, English J, Tymianski M; ESCAPE-NA1 Investigators.

Lancet. 2020 Mar 14;395(10227):878-887. doi: 10.1016/S0140-6736(20)30258-0. Epub 2020 Feb 20.

PMID:
32087818
30.

Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.

Ferrannini G, De Bacquer D, De Backer G, Kotseva K, Mellbin L, Wood D, Rydén L; EUROASPIRE V collaborators.

Diabetes Care. 2020 Apr;43(4):726-733. doi: 10.2337/dc19-2165. Epub 2020 Feb 20.

PMID:
32079627
31.

Journée du cancer : mobiliser autour de la prévention.

Peters S, Dietrich PY.

Rev Med Suisse. 2020 Feb 19;16(682):382-383. French. No abstract available.

PMID:
32073779
32.

Nine newly identified individuals refine the phenotype associated with MYT1L mutations.

Windheuser IC, Becker J, Cremer K, Hundertmark H, Yates LM, Mangold E, Peters S, Degenhardt F, Ludwig KU, Zink AM, Lessel D, Bierhals T, Herget T, Johannsen J, Denecke J, Wohlleber E, Strom TM, Wieczorek D, Bertoli M, Colombo R, Hempel M, Engels H.

Am J Med Genet A. 2020 Feb 17. doi: 10.1002/ajmg.a.61515. [Epub ahead of print]

PMID:
32065501
33.

New Billing Rules for Outpatient Office Visit Codes.

Peters SG.

Chest. 2020 Feb 10. pii: S0012-3692(20)30253-1. doi: 10.1016/j.chest.2020.01.028. [Epub ahead of print] Review.

PMID:
32057804
34.

Variability in lutetium-177 SPECT quantification between different state-of-the-art SPECT/CT systems.

Peters SMB, Meyer Viol SL, van der Werf NR, de Jong N, van Velden FHP, Meeuwis A, Konijnenberg MW, Gotthardt M, de Jong HWAM, Segbers M.

EJNMMI Phys. 2020 Feb 11;7(1):9. doi: 10.1186/s40658-020-0278-3.

35.

Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?

Schmid S, Früh M, Peters S.

Lancet Oncol. 2020 Mar;21(3):320-322. doi: 10.1016/S1470-2045(19)30859-9. Epub 2020 Feb 3. No abstract available.

PMID:
32027845
36.

Moving Sport and Exercise Science Forward: A Call for the Adoption of More Transparent Research Practices.

Caldwell AR, Vigotsky AD, Tenan MS, Radel R, Mellor DT, Kreutzer A, Lahart IM, Mills JP, Boisgontier MP; Consortium for Transparency in Exercise Science (COTES) Collaborators.

Sports Med. 2020 Mar;50(3):449-459. doi: 10.1007/s40279-019-01227-1.

PMID:
32020542
37.

Recovery from postpartum psychosis: a systematic review and metasynthesis of women's and families' experiences.

Forde R, Peters S, Wittkowski A.

Arch Womens Ment Health. 2020 Feb 4. doi: 10.1007/s00737-020-01025-z. [Epub ahead of print] Review.

PMID:
32020314
38.

Oral Pseudomyogenic Hemangioendothelioma: Case Report and Review of the Literature.

Shackelford AJ, Canterbury CR, Perrino MA, Wang J, Philipone EM, Peters SM.

Head Neck Pathol. 2020 Feb 3. doi: 10.1007/s12105-020-01137-z. [Epub ahead of print]

PMID:
32016785
39.

An unexpected cause of wheezing and shortness of breath.

Peters SM.

JAAPA. 2020 Feb;33(2):54-56. doi: 10.1097/01.JAA.0000651768.07482.f9. No abstract available.

PMID:
31990838
40.

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S.

Ann Oncol. 2019 May;30(5):863-870. doi: 10.1093/annonc/mdy474. Epub 2019 Dec 4. No abstract available.

PMID:
31987360
41.

Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA.

He W, Evans AC, Rasley A, Bourguet F, Peters S, Kamrud KI, Wang N, Hubby B, Felderman M, Gouvis H, Coleman MA, Fischer NO.

Nanomedicine. 2020 Feb;24:102154. doi: 10.1016/j.nano.2020.102154. Epub 2020 Jan 24.

42.

Prediction of active human dose: learnings from 20 years of Merck KGaA experience, illustrated by case studies.

Peters SA, Petersson C, Blaukat A, Halle JP, Dolgos H.

Drug Discov Today. 2020 Jan 22. pii: S1359-6446(20)30028-3. doi: 10.1016/j.drudis.2020.01.002. [Epub ahead of print] Review.

43.

MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality.

Yoon AJ, Wang S, Kutler DI, Carvajal RD, Philipone E, Wang T, Peters SM, LaRoche D, Hernandez BY, McDowell BD, Stewart CR, Momen-Heravi F, Santella RM.

Head Neck. 2020 Jan 25. doi: 10.1002/hed.26089. [Epub ahead of print]

PMID:
31981257
44.

A flexible 3-dimensional microelectrode array for in vitro brain models.

Soscia DA, Lam D, Tooker AC, Enright HA, Triplett M, Karande P, Peters SKG, Sales AP, Wheeler EK, Fischer NO.

Lab Chip. 2020 Mar 3;20(5):901-911. doi: 10.1039/c9lc01148j.

PMID:
31976505
45.

MRI in patients with implanted active devices: how to combine safety and image quality using a limited transmission field?

Lunden L, Wolff S, Peters S, Drews C, Gierloff C, Jensen-Kondering U, Langguth P, Madjidyar J, Piesch TC, Jansen O.

Eur Radiol. 2020 Jan 23. doi: 10.1007/s00330-019-06599-6. [Epub ahead of print]

PMID:
31974690
46.

Familial Dilated Cardiomyopathy.

Peters S, Johnson R, Birch S, Zentner D, Hershberger RE, Fatkin D.

Heart Lung Circ. 2020 Apr;29(4):566-574. doi: 10.1016/j.hlc.2019.11.018. Epub 2019 Dec 17. Review.

PMID:
31974027
47.

Teardrop-shaped radiolucency of the mandible.

Lee KC, Chen JX, Furmanek K, Eisig SB, Peters SM.

J Am Dent Assoc. 2020 Jan 20. pii: S0002-8177(19)30847-5. doi: 10.1016/j.adaj.2019.11.020. [Epub ahead of print] No abstract available.

PMID:
31973790
48.

[Advances in Oncology 2019].

Vernadou A, Ferahta N, Mederos N, Ferraro D, Dischl-Antonioni I, Diciolla A, Liapi A, Mosimann V, Latifyan S, Aedo-Lopez V, Berthold D, Digklia A, Michielin O, Montemurro M, Wagner AD, Zaman K, Peters S, Stravodimou A, Sarivalasis A.

Rev Med Suisse. 2020 Jan 15;16(676-7):72-77. Review. French.

PMID:
31961089
49.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.

Park K, Vansteenkiste J, Lee KH, Pentheroudakis G, Zhou C, Prabhash K, Seto T, Voon PJ, Tan DSW, Yang JCH, Wang J, Babu KG, Nakayama Y, Alip A, Chua KLM, Cheng JC, Senan S, Ahn YC, Kim TY, Ahn HK, Peters S, Yoshino T, Douillard JY.

Ann Oncol. 2020 Feb;31(2):191-201. doi: 10.1016/j.annonc.2019.10.026. Epub 2019 Dec 20.

PMID:
31959336
50.

Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort.

Burkes RM, Ceppe AS, Doerschuk CM, Couper D, Hoffman EA, Comellas AP, Barr RG, Krishnan JA, Cooper C, Labaki WW, Ortega VE, Wells JM, Criner GJ, Woodruff PG, Bowler RP, Pirozzi CS, Hansel NN, Wise RA, Brown TT, Drummond MB; SPIROMICS Investigators.

Chest. 2020 Apr;157(4):856-865. doi: 10.1016/j.chest.2019.11.047. Epub 2020 Jan 17.

PMID:
31958447

Supplemental Content

Loading ...
Support Center